Development Progress
Total human exposures > 200
Dosed in Type I and II patients
- Glucose clamp study
- Fed-fasted study
- Night-time insulin study
Fed Study: Will oral insulin be effective under real-life conditions before a solid meal?
- Established that oral insulin / EMISPHERE® delivery agent has a therapeutic effect in Type I and Type II patients following their ingestion of a mixed meal
90-day toxicity data supports planned multi-dose study
Reproducible delivery from capsule dosage forms demonstrated